Nektar Therapeutics (NKTR) Insider Trading
- $1,135,850.00
- $232,543,735.70
- Nov. 19, 2024
- Howard W Robin
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 7, 2018 | Director | 40,000 | $97.60 | Sell | $3,904,000.00 | |
Feb. 16, 2018 | CAO | 2,545 | $82.94 | Sell | $211,082.30 | |
Feb. 16, 2018 | CFO | 3,477 | $82.94 | Sell | $288,382.38 | |
Feb. 16, 2018 | COO | 4,879 | $82.94 | Sell | $404,664.26 | |
Feb. 16, 2018 | CEO | 12,788 | $82.94 | Sell | $1,060,636.72 | |
Feb. 16, 2018 | SVP | 2,426 | $82.94 | Sell | $201,212.44 | |
Jan. 22, 2018 | CEO | 83,333 | $75.82 | Sell | $6,318,308.06 | |
Jan. 2, 2018 | Director | 30,000 | $58.66 | Sell | $1,759,800.00 | |
Dec. 13, 2017 | CEO | 83,333 | $55.69 | Sell | $4,640,814.77 | |
Nov. 13, 2017 | COO | 15,910 | $37.78 | Sell | $601,079.80 | |
Nov. 8, 2017 | SVP | 396,323 | $29.00 | Sell | $11,493,367.00 | |
Nov. 6, 2017 | SVP | 5,117 | $25.07 | Sell | $128,283.19 | |
Nov. 1, 2017 | CEO | 83,334 | $23.57 | Sell | $1,964,182.38 | |
Oct. 9, 2017 | CEO | 83,333 | $24.20 | Sell | $2,016,658.60 | |
Oct. 5, 2017 | SVP | 43,677 | $24.97 | Sell | $1,090,614.69 | |
Oct. 2, 2017 | CFO | 120,000 | $24.45 | Sell | $2,934,000.00 | |
Oct. 2, 2017 | SVP | 100,000 | $24.14 | Sell | $2,414,000.00 | |
Sept. 22, 2017 | Director | 4,000 | $21.86 | Sell | $87,440.00 | |
Sept. 21, 2017 | Director | 6,400 | $21.72 | Sell | $139,008.00 | |
Sept. 6, 2017 | CEO | 83,333 | $21.54 | Sell | $1,794,992.82 | |
Aug. 16, 2017 | CEO | 91,714 | $19.26 | Sell | $1,766,411.64 | |
Aug. 16, 2017 | SVP | 1,701 | $19.32 | Sell | $32,863.32 | |
Aug. 16, 2017 | COO | 3,177 | $19.32 | Sell | $61,379.64 | |
Aug. 16, 2017 | CAO | 2,648 | $19.32 | Sell | $51,159.36 | |
Aug. 10, 2017 | Director | 35,000 | $17.95 | Buy | $628,250.00 | |
July 18, 2017 | SVP | 54,920 | $21.10 | Sell | $1,158,812.00 | |
July 14, 2017 | Director | 30,000 | $20.76 | Sell | $622,800.00 | |
July 12, 2017 | SVP | 45,080 | $21.08 | Sell | $950,286.40 | |
July 11, 2017 | SVP | 8,389 | $21.04 | Sell | $176,504.56 | |
May 16, 2017 | SVP | 1,701 | $19.55 | Sell | $33,254.55 | |
May 16, 2017 | CFO | 3,179 | $19.55 | Sell | $62,149.45 | |
May 16, 2017 | CEO | 8,388 | $19.55 | Sell | $163,985.40 | |
May 16, 2017 | COO | 3,146 | $19.55 | Sell | $61,504.30 | |
May 15, 2017 | Director | 5,000 | $19.79 | Sell | $98,950.00 | |
April 17, 2017 | Director | 5,000 | $18.72 | Sell | $93,600.00 | |
April 7, 2017 | Director | 7,000 | $20.05 | Sell | $140,350.00 | |
April 5, 2017 | Director | 15,000 | $21.88 | Sell | $328,200.00 | |
April 5, 2017 | SVP | 180,000 | $21.70 | Sell | $3,906,000.00 | |
March 20, 2017 | SVP | 112,500 | $19.69 | Sell | $2,215,125.00 | |
March 3, 2017 | CFO | 200,000 | $15.16 | Sell | $3,032,000.00 | |
Feb. 16, 2017 | SVP | 1,457 | $13.14 | Sell | $19,144.98 | |
Feb. 16, 2017 | CEO | 8,636 | $13.14 | Sell | $113,477.04 | |
Feb. 16, 2017 | CFO | 2,359 | $13.14 | Sell | $30,997.26 | |
Feb. 16, 2017 | COO | 3,237 | $13.14 | Sell | $42,534.18 | |
Feb. 8, 2017 | CEO | 87,500 | $13.04 | Sell | $1,141,000.00 | |
Feb. 3, 2017 | COO | 75,000 | $12.39 | Sell | $929,250.00 | |
Jan. 17, 2017 | CEO | 87,500 | $12.35 | Sell | $1,080,625.00 | |
Nov. 17, 2016 | CEO | 93,458 | $13.88 | Sell | $1,297,197.04 | |
Oct. 24, 2016 | Director | 15,000 | $13.50 | Buy | $202,500.00 | |
Oct. 4, 2016 | CEO | 87,500 | $17.06 | Sell | $1,492,750.00 |
Insiders are both buying and selling Nektar Therapeutics stock.
The insider traders at Nektar Therapeutics are: Howard W Robin, Gil M. Labrucherie, Jillian B. Thomsen, Robert Chess, Jonathan Zalevsky, John Nicholson, Gil M Labrucherie, Howard W. Robin, Stephen K Doberstein, Jillian B Thomsen, Lutz Lingnau, Mark Andrew Wilson, Ivan P Gergel, Maninder Hora, Jeffrey Robert Ajer, R Scott Greer, Dennis L Winger, Christopher A Kuebler, Myriam Curet, Susan Wang, Christopher A. Kuebler, Roy A Whitfield, Karin Eastham, Curet Myriam, Roy Whitfield, John Northcott, Deep Track Capital, Lp, Stephen K. Doberstein, and Katharina Otto-Bernstein
The most active insider trader at Nektar Therapeutics is Howard W Robin with 49 trades.
Howard W Robin has sold the most Nektar Therapeutics stock with a total value of $84,286,240.28.
Roy A Whitfield has bought the most Nektar Therapeutics stock with a total value of $1,256,500.00.
The most recent insider trade for Nektar Therapeutics was on Nov. 19, 2024.
The single biggest insider buy for Nektar Therapeutics was from Roy A Whitfield with a total value of $628,250.00 on Aug. 10, 2017.
The single biggest insider sell for Nektar Therapeutics was from John Nicholson with a total value of $21,853,694.88 on March 7, 2018.